![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
CuFe2O4 decorated with BSA as a potential nanoradioenhancer for enhanced X-ray radiation therapy of brain tumor
Glioblastoma (GBM) is a type of the central nervous system malignancy and considered as the most lethal and aggressive primary brain tumor. Adjuvant radiotherapy (RT) along with temozolomide (TMZ) is considere...
-
Chapter
Harnessing the Power of Nanomaterials to Alleviate Tumor Hypoxia in Favor of Cancer Therapy
Cancer hypoxia is considered a hallmark of almost all solid malignancy and is responsible for diminishing the efficacy of some important cancer therapy modalities, particularly for those dependent on oxygen, i...
-
Chapter
ROS-Based Cancer Radiotherapy
Reactive oxygen species (ROS) in cancer cells play a crucial role in metabolic reprogramming, altering tumor microenvironment, regulating cell death, repairing DNA and other physiological functions of living o...
-
Chapter
Radiosensitizers in Radiation-Induced Cancer Therapy
Radiation therapy (RT) has established as a very auspicious tool to tackle cancer, but its efficacy has encountered with some challenges. As we all know, in the case of cancer therapy by RT, high doses of radi...
-
Chapter
Application of Nanoradioprotective Agents in Cancer Therapy
Radiotherapy (RT) has been widely employed in health centers and hospitals for the treatment of several malignant tumors. The main goal of RT is to augment the therapeutic efficacy of treatment by delivering s...